Engineers devised a way to purify protein drugs during manufacturing. Their approach, which uses nanoparticles to rapidly crystallize proteins, could help make protein drugs more affordable and ...
New technologies in upstream biopharmaceutical production continue to increase yields and protein product quantities at the bioreactor. However, these higher titers, larger yields, and shorter ...
One of the most expensive steps in manufacturing protein drugs such as antibodies or insulin is the purification step: isolating the protein from the bioreactor used to produce it. This step can ...
Biopharmaceutical manufacturing involves a balancing act between the capacity of cell culture and downstream purification. Balancing the two has always been difficult because construction decisions ...
CAMBRIDGE, MA -- One of the most expensive steps in manufacturing protein drugs such as antibodies or insulin is the purification step: isolating the protein from the bioreactor used to produce it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results